Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance

OBJECTIVE: To evaluate the safety profile of ixazomib combined with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) in clinical practice in Japan through an all-case post-marketing surveillance. METHODS: This was a nationwide non-interventional observation...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakimoto, Yoshihide, Hoshino, Miyako, Hashimoto, Mikiko, Hiraizumi, Masaya, Shimizu, Kohei, Chou, Takaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152867/
https://www.ncbi.nlm.nih.gov/pubmed/34645759
http://dx.doi.org/10.2169/internalmedicine.7768-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152867/
https://www.ncbi.nlm.nih.gov/pubmed/34645759
http://dx.doi.org/10.2169/internalmedicine.7768-21

Ejemplares similares